We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants
NUVB.WS

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

Back to rankings

22 hedge funds and large institutions have $4.11M invested in Nuvation Bio Inc Warrants in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more funds holding

Funds holding: 20 → 22 (+2)

0.06% more ownership

Funds ownership: 1.81% → 1.87% (+0.06%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

47% less capital invested

Capital invested by funds: $7.76M → $4.11M (-$3.65M)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
+$85.8K
2
ACP
Acuta Capital Partners
California
+$58.4K
3
UBS Group
UBS Group
Switzerland
+$134
4
Citadel Advisors
Citadel Advisors
Florida
+$70

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$56.3K
2
IP
Intellectus Partners
California
-$1.21K
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$3.12M – – –
6CM
2
683 Capital Management
New York
$234K – – –
HCM
3
Highbridge Capital Management
New York
$110K – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$75K – – –
BC
5
Boxer Capital
California
$75K – – –
Franklin Resources
6
Franklin Resources
California
$75K – – –
CCA
7
Castle Creek Arbitrage
Colorado
$62K – – –
DM
8
Deerfield Management
New York
$47K – – –
BlackRock
9
BlackRock
New York
$44K – – –
RSCM
10
Rock Springs Capital Management
Maryland
$38K – – –
SB
11
Samsara BioCapital
California
$37K +$85.8K +133,333 New
APM
12
Avidity Partners Management
Texas
$28K – – –
GC
13
Greenlight Capital
New York
$28K – – –
ACP
14
Acuta Capital Partners
California
$25K +$58.4K +90,832 New
Walleye Capital
15
Walleye Capital
New York
$22K -$56.3K -87,505 -53%
Citadel Advisors
16
Citadel Advisors
Florida
$21K +$70 +109 +0.1%
LGM
17
Logos Global Management
California
$19K – – –
Victory Capital Management
18
Victory Capital Management
Texas
$18K – – –
MA
19
MYDA Advisors
New York
$11K – – –
CC
20
Clearline Capital
New York
$9K – – –
IP
21
Intellectus Partners
California
$6K -$1.21K -1,875 -8%
Barclays
22
Barclays
United Kingdom
$1K – – –
UBS Group
23
UBS Group
Switzerland
$1K +$134 +208 +11%

NUVB.WS Hedge Fund Activity: Q2 2022 in Review

22 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q2 2022, worth a combined $4.11M — down 47% from $7.76M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NUVB.WS positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Samsara BioCapital, opening a new position worth an estimated $85.8K. The largest seller was Walleye Capital, cutting an estimated $56.3K.

  • 22 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q2 2022, up from 20 in Q1 2022.
  • Funds reported $4.11M of Nuvation Bio Inc Warrants stock for Q2 2022, down 47% quarter-over-quarter.
  • 2 funds opened new Nuvation Bio Inc Warrants positions in Q2 2022 and 0 closed out, a net change of +2 holders.
  • The largest Nuvation Bio Inc Warrants buyer in Q2 2022 was Samsara BioCapital, an estimated $85.8K added.
  • The largest Nuvation Bio Inc Warrants seller in Q2 2022 was Walleye Capital, an estimated $56.3K sold.

Based on aggregated 13F filings for Q2 2022.